Neurogene
NGNE
19 hedge funds and large institutions have $41.1M invested in Neurogene in 2014 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 6 closing their positions.
17% less funds holding
Funds holding: 23 → 19 (-4)
31% less capital invested
Capital invested by funds: $59.6M → $41.1M (-$18.5M)
50% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 6
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$1.06M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$512K |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
+$99.7K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$9.65K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$1.72M |
| 2 |
Jennison Associates
New York
|
-$955K |
| 3 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
-$869K |
| 4 |
DM
Deerfield Management
New York
|
-$794K |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$382K |
NGNE Hedge Fund Activity: Q2 2014 in Review
19 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Neurogene (NGNE) for Q2 2014, worth a combined $41.1M — down 31% from $59.6M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of NGNE and 2 opened new positions — a net loss of 4 holders — while 6 trimmed existing stakes and 3 added.
The largest buyer was Franklin Resources, adding an estimated $1.06M. The largest seller was Driehaus Capital Management, cutting an estimated $1.72M.
- 19 institutional investors held Neurogene (NGNE) as of Q2 2014, down from 23 in Q1 2014.
- Funds reported $41.1M of Neurogene stock for Q2 2014, down 31% quarter-over-quarter.
- 2 funds opened new Neurogene positions in Q2 2014 and 6 closed out, a net change of -4 holders.
- The largest Neurogene buyer in Q2 2014 was Franklin Resources, an estimated $1.06M added.
- The largest Neurogene seller in Q2 2014 was Driehaus Capital Management, an estimated $1.72M sold.
Based on aggregated 13F filings for Q2 2014.